InspireMD, Inc.
NSPR
$2.56
-$0.10-3.76%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.68% | 16.32% | 5.46% | 21.95% | 71.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.68% | 16.32% | 5.46% | 21.95% | 71.64% |
| Cost of Revenue | 17.83% | 24.87% | 21.59% | 40.76% | 51.69% |
| Gross Profit | -7.13% | -5.48% | -32.59% | -21.72% | 155.05% |
| SG&A Expenses | 43.60% | 25.06% | 36.11% | 74.54% | 37.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.50% | 42.77% | 43.58% | 58.81% | 26.95% |
| Operating Income | -61.28% | -50.06% | -55.41% | -69.23% | -17.67% |
| Income Before Tax | -70.69% | -52.38% | -55.78% | -65.23% | -10.86% |
| Income Tax Expenses | -9.23% | -- | -- | -- | 132.14% |
| Earnings from Continuing Operations | -69.73% | -52.38% | -55.78% | -65.23% | -11.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -69.73% | -52.38% | -55.78% | -65.23% | -11.56% |
| EBIT | -61.28% | -50.06% | -55.41% | -69.23% | -17.67% |
| EBITDA | -61.68% | -50.37% | -55.87% | -69.79% | -17.72% |
| EPS Basic | -16.74% | -7.02% | 8.51% | 60.94% | 73.35% |
| Normalized Basic EPS | -14.47% | -7.04% | 8.50% | 60.97% | 75.10% |
| EPS Diluted | -16.74% | -7.02% | 8.51% | 60.38% | 73.35% |
| Normalized Diluted EPS | -14.47% | -7.04% | 8.50% | 60.97% | 75.10% |
| Average Basic Shares Outstanding | 45.39% | 42.33% | 70.25% | 323.10% | 318.53% |
| Average Diluted Shares Outstanding | 45.39% | 42.33% | 70.25% | 323.10% | 318.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
